Yüklüyor......
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial
IMPORTANCE: Although the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for EGFR gene mutation–positive non–small cell lung cancer is well established, optimal dosing remains to be established, especially in elderly or frail patients. OBJECTIVE: To investigate the efficacy a...
Kaydedildi:
| Yayımlandı: | JAMA Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Medical Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7226294/ https://ncbi.nlm.nih.gov/pubmed/32407455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.1250 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|